Bibliography
- Loesche WJ. Role of Streptococcus mutans in human dental decay. Microbiol Rev 1986;50:353-80
- Kazuhiko N. Ryota N.; Takashi O. Streptococcus mutans and cardiovascular diseases. Japan Dent Sci Rev 2008;44:29-37
- Ajdić D, Pham VT. Global transcriptional analysis of Streptococcus mutans sugar transporters using microarrays. J Bacteriol 2007;189:5049-59
- Simón-Soro A, Mira A. Solving the etiology of dental caries. Trends Microbiol 2015;23:76-82
- Dhamodhar P, Murthy S, Channarayappa RK, et al. Antibacterial efficacy of Syzygium aromaticum extracts on multi-drug resistant Streptococcus mutans isolated from dental plaque samples. Journal of Biochemical Technology. J Biochem Technol 2012;3:155-7
- Koo H, Benoit D, Klein MI, Falsetta Wood ML. Nanoparticles for the controlled release of anti-biofilm agents. WO 2014/130994
- Bush K, Macielag MJ. New β-lactam antibiotics and β- lactamase inhibitors. Expert Opin Ther Pat 2010;20:1277-93
- Capasso C, Supuran CT. Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors. J Enzyme Inhib Med Chem 2014;29:379-87
- Capasso C, Supuran CT. Antiinfective carbonic anhydrase inhibitors: A patent and literature review. Expert Opin Ther Pat 2013;29:693-704
- Furtado GH, Nicolau DP. Overview perspective of bacterial resistance. Expert Opin Ther Pat 2010;20:1273-6
- Dedeoglu N, DeLuca V, Isik S, et al. Sulfonamide inhibition study of the β-7class carbonic anhydrase from the caries producing pathogen Streptococcus mutans. Bioorg Med Chem Lett 2015;25:2291-7
- Supuran CT. Bacterial carbonic anhydrases as drug targets: towards novel antibiotics? Front Pharmacol 2011;2:34
- Stiti M, Cecchi A, Rami M, et al. Carbonic anhydrase inhibitor coated gold nanoparticles selectively inhibit the tumor-associated isoform IX over the cytosolic ubiquitous isozymes I and II. J Am Chem Soc 2008;130:16130-1
- Saada MC, Montero JL, Winum JY, et al. Carbonic anhydrase activators: gold nanoparticles coated with derivatized histamine, histidine and carnosine show enhanced activatory effects on several mammalian isoforms. J Med Chem 2011;54:1170-7
- Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759-72
- Balboni G, Congiu C, Onnis V, et al. Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins. Bioorg Med Chem Let 2012;22:3063-6
- Ekinci D, Karagoz L, Ekinci D, et al. Carbonic anhydrase inhibitors: in vitro inhibition of α isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids. J Enzyme Inhib Med Chem 2013;28:283-8
- Nishimori I, Minakuchi T, Vullo D, et al. Carbonic anhydrase inhibitors. cloning, characterization, and inhibition studies of a new β-carbonic anhydrase from Mycobacterium tuberculosis. J Med Chem 2009;52:3116-20
- Burghout P, Vullo D, Scozzafava A, Hermans PWM. Supuran CT Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: towards innovative drug design of antiinfectives? Bioorg Med Chem 2011;19:243-8
- Winum JY, Kohler S, Supuran CT. Brucella carbonic anhydrases: New targets for designing anti-infective agents. Curr Pharm Des 2010;16:3310-16
- Maresca A, Carta F, Vullo D, Supuran CT. Dithiocarbamates strongly inhibit the β-class carbonic anhydrases from Mycobacterium tuberculosis. J Enzyme Inhib Med Chem 2013;28:407-11
- Maresca A, Scozzafava A, Vullo D, Supuran CT. Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three β-class carbonic anhydrases from Mycobacterium tuberculosis. J Enzyme Inhib Med Chem 2013;28:384-7
- Maresca A, Vullo D, Scozzafava A, Supuran CT. Inhibition of the alpha- and beta- carbonic anhydrases from the gastric pathogen Helicobacter pylori with anions. J Enzyme Inhib Med Chem 2013;28:388-91